Table 10. Analysis of changes in CK2 gene expression in monoclonal gammopathies.
P-values, fold change, rank and datasets are shown.
Gene | p-value | Fold Change | Rank (Top %) | Dataset | #Samples | Reference |
---|---|---|---|---|---|---|
Monoclonal Gammopathy of Undetermined Significance (MGUS) | ||||||
CK2α | 1.18 10−6 | 1.594 | 4% | Zhan Myeloma 3 | 78 | [115] |
6.61 10−5 | -1.619 | 1% | Agnelli Myeloma 3 | 158 | [114] | |
CK2α’ | 0.003 | 1.225 | 26% | Zhan Myeloma 3 | 78 | [115] |
CK2β | 0.001 | 1.308 | 21% | Zhan Myeloma 3 | 78 | [115] |
Smoldering Myeloma | ||||||
CK2α | 3.36 10−9 | 1.763 | 1% | Zhan Myeloma 3 | 78 | [115] |
CK2α’ | 0.002 | 1.378 | 32% | Zhan Myeloma 3 | 78 | [115] |
CK2β | 1.73 10−4 | 1.779 | 22% | Zhan Myeloma 3 | 78 | [115] |
Plasma Cell Leukemia | ||||||
CK2α | 0.001 | 1.881 | 8% | Agnelli Myeloma 3 | 158 | [114] |
CK2β | 6.4 10−4 | 1.461 | 7% | Agnelli Myeloma 3 | 158 | [114] |